Literature DB >> 7274624

Target-cell cytotoxicity of a hybrid of Fab' on immunoglobulin and A-chain of ricin.

Y Masuho, T Hara.   

Abstract

As an approach to the development of new antitumor agents, a hybrid in which one molecule of the Fab' fragment of a rabbit anti-murine leukemia L1210 immunoglobulin G (IgG) was linked to the A-chain of ricin via a disulfide bone was prepared by the reaction of A-chain having one reactive thiol group with Fab' having one activated cysteine residue, followed by chromatography on Sephadex G-150 superfine. The hybrid exhibited a potent cytotoxicity towards L1210, whereas unconjugated Fab', unconjugated A-chain, or an equimolar mixture of the two showed no significant cytotoxicity. Furthermore, the hybrid with Fab' of normal IgG had no cytotoxicity towards L1210 cells. The results indicate that the hybrid manifests its toxic activity towards the target cells through binding of its Fab' moiety of cell surface antigens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7274624

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  5 in total

1.  Cytotoxicities of two disulfide-bond-linked conjugates of methotrexate with monoclonal anti-MM46 antibody.

Authors:  N Umemoto; Y Kato; T Hara
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Ricin A-chain conjugated with monoclonal anti-L1210 antibody. In vitro and in vivo antitumor activity.

Authors:  K Kishida; Y Masuho; M Saito; T Hara; H Fuji
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

3.  Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain.

Authors:  E S Vitetta; R J Fulton; J W Uhr
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

4.  Selective cytotoxic effects of a ricin A chain immunotoxin made with the monoclonal antibody SWA11 recognising a human small cell lung cancer antigen.

Authors:  E J Wawrzynczak; E J Derbyshire; R V Henry; G D Parnell; A Smith; R Waibel; R A Stahel
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

5.  In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.

Authors:  K A Krolick; J W Uhr; S Slavin; E S Vitetta
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.